- Home
- SLRX vs EAD Comparison
SLRX vs EAD Comparison
Compare SLRX & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- EAD
- Stock Information
- Founded
- SLRX N/A
- EAD 2003
- Country
- SLRX United States
- EAD United States
- Employees
- SLRX N/A
- EAD N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- EAD Finance/Investors Services
- Sector
- SLRX Health Care
- EAD Finance
- Exchange
- SLRX Nasdaq
- EAD Nasdaq
- Market Cap
- SLRX 1.8M
- EAD 406.6M
- IPO Year
- SLRX N/A
- EAD N/A
- Fundamental
- Price
- SLRX $0.65
- EAD $7.06
- Analyst Decision
- SLRX
- EAD
- Analyst Count
- SLRX 0
- EAD 0
- Target Price
- SLRX N/A
- EAD N/A
- AVG Volume (30 Days)
- SLRX 312.1K
- EAD 178.9K
- Earning Date
- SLRX 08-08-2025
- EAD 01-01-0001
- Dividend Yield
- SLRX N/A
- EAD 8.91%
- EPS Growth
- SLRX N/A
- EAD N/A
- EPS
- SLRX N/A
- EAD N/A
- Revenue
- SLRX N/A
- EAD N/A
- Revenue This Year
- SLRX N/A
- EAD N/A
- Revenue Next Year
- SLRX N/A
- EAD N/A
- P/E Ratio
- SLRX N/A
- EAD N/A
- Revenue Growth
- SLRX N/A
- EAD N/A
- 52 Week Low
- SLRX $0.45
- EAD $5.69
- 52 Week High
- SLRX $7.20
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- SLRX 34.94
- EAD 65.25
- Support Level
- SLRX $0.60
- EAD $7.04
- Resistance Level
- SLRX $0.70
- EAD $7.14
- Average True Range (ATR)
- SLRX 0.09
- EAD 0.05
- MACD
- SLRX -0.03
- EAD -0.01
- Stochastic Oscillator
- SLRX 5.95
- EAD 61.17
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.